🎙️ Avantor's CEO, Michael Stubblefield, is set to participate in a fireside chat at the Evercore ISI HealthConX Conference on Dec. 3rd. 🔬 Avantor partners with Quantum-Si to distribute their next-gen protein sequencing technology, broadening research possibilities. 🧪 Avantor unveils its new flagship Bridgewater Innovation Center, dedicated to tackling life science's biggest challenges. 📝 Dame Louise Makin, DBE, Ph.D., joins Avantor's Board of Directors, strengthening their leadership team. 💼 Avantor's Q3 2024 results: Net sales at $1.71B, net income at $57.8M, and free cash flow at $204M. #DataPorium #Avantor #LifeSciences #Innovation #FinancialResults At DataPorium, we track the financial performance, product sales, market share, and social network analysis. We also track the trends of nearly 1,000 products every quarter. 🚀 Want to see more? Head over to https://lnkd.in/duDAwekv and explore! 🔗 Visit our LinkedIn page https://lnkd.in/gJ2iKqKw today for exclusive updates—completely free!
DataPorium’s Post
More Relevant Posts
-
Early bird rates end June 3 for BioCentury Grand Rounds – an R&D conference in Nashville for academic innovators, researchers, investors and industry leaders to explore the translational science behind the next wave of biotech breakthroughs and the people driving them. Take advantage of these special rates and make connections with peers across the biopharma sphere as we discuss: ➤ What Investors Want: Gain insights from top investors on what they’re looking for in today’s market. ➤ New Investible Space: Discover emerging sectors and opportunities that are catching the eye of investors. ➤ Measurements of Translational Success: Learn how to measure and showcase the impact of your innovations. Register now to secure your spot at #BioCenturyGrandRounds: https://loom.ly/yydzbC8 Submit your nominations to join the Presenting Companies Class of 2024 by June 3 to lock in early bird rates: https://loom.ly/GHHuDog #GrandRounds #BiotechBreakthroughs #researchdevelopment #academia #venturecapital #biotech #drugdiscovery #drugdevelopment #RnD
To view or add a comment, sign in
-
📊 Market Movers Update 📊 In the tempestuous tides of today's market, distinct stocks have made credible headway, while others have encountered significant declines. Topping the chart of market gainers are Health Technology giants - Summit Therapeutics, Aligos Therapeutics, and SiNtx Technologies, experiencing substantial stock increases of around 55%, underscoring their potent market authority and perpetual innovation. Contrastingly, Astrotech Corporation from the Electronic Technology sector, along with Guardion Health Sciences and Binah Capital Group from Health Technology and Finance sectors respectively, have seen their shares suffer considerable dips. A vigilant approach towards these dramatic market fluctuations is indispensable for strategic financial decision-making. 💡 Key Insights: ✔️ Summit Therapeutics, Aligos Therapeutics, and SiNtx Technologies display powerful market presence, with significant stock surges. ✔️ Astrotech Corporation, Guardion Health Sciences, and Binah Capital Group are currently facing market challenges, evidenced by the steep falls in their stocks. ✔️ Continuous tracking of top market gainers and losers can influence robust investment strategies. Stay informed, stay ahead. 🚀 #Trading #MarketNews #Investing #StockMarket #FinancialDecisions #MarketFluctuations Content shared by Zimtra is for informational purposes only, and not trading advice. Always do your own research before making any investment., Click https://lnkd.in/ea_TV6AK for more information.
To view or add a comment, sign in
-
My mission, to build a stellar technology by empowering the best and learn from the brightest. With a degree in Physics, a slight paraphrase of the famous quote by Sir Isac Newton fits well here: you see further “by standing on the shoulders of giants”
🚀 We are thrilled to welcome Nick Roelofs as our Strategic Business Advisor! Nicolas brings over 40 years of leadership in the life sciences tools and diagnostics industry, having shaped the strategic direction of companies like Agilent Technologies and Bio-Rad Laboratories. He is widely recognized for his strategic vision and operational excellence, with a passion for bringing new technologies to market and helping companies transition from start-up to scale-up. “Having Nick onboard as an advisor is fantastic. This is not the first time Nick is working with padlock-technologies and his commercial experience from Halo Genomics AB and Olink Proteomics are particularly relevant in crafting and refining our commercial and funding strategies“ Linus Bosaeus, CEO Rarity Bioscience Please join us in welcoming Nick to the team! 🙌 #RarityBioscience #superRCA #CareerDevelopment #newhiring #welcometotheteam #cancerdiagnosis Read more about Nicolas joining Rarity here: https://lnkd.in/d9JYWdM9
To view or add a comment, sign in
-
Dear LinkedIn Community, I'm thrilled to invite you all to an upcoming event that promises to be both informative and engaging! Whether you're from academic, an aspiring entrepreneur, or someone looking to expand your network, this event is for you. Biotech Innovation Funding Networking in LA. 📅 Date: April 6th, 2024 ⏰ Time: 1:00-5:00 pm 📍 ☀️ ScaleHealth 3415 S Sepulveda Blvd FL 10 Los Angeles, CA 90034 Join us! ➡️ https://lnkd.in/euDuGG4m This highly anticipated event will serve as a gathering ground for biotech leaders, founders, and investors, all with the shared objective of identifying the next billion-dollar unicorn. Our aim is not only to connect and unite the biotech ecosystem in the USA but also to foster collaboration and drive advancements in the APAC region, collectively shaping the future of the life science industry. As a testament to their outstanding achievements, each winner will be granted the privilege of being featured on the prestigious GeneOnline and TiBIA platforms. This exposure will provide them with valuable visibility and recognition within the industry. Additionally, the winners will be presented with a special prize, further acknowledging their remarkable contributions and accomplishments. Registration here. Biotech Innovation Funding Networking Tickets, Sat, Apr 6, 2024 at 1:00 PM Why Should You Attend? 1️⃣ Networking: Connect with like-minded individuals, potential collaborators, and industry experts. 2️⃣ Knowledge Sharing: Gain valuable insights and learn from seasoned professionals in your field. 3️⃣ Inspiration: Get inspired by success stories, innovative ideas, and impactful strategies. 4️⃣ Opportunity: Discover new opportunities, partnerships, and pathways to success. This event is open to all professionals, entrepreneurs, students, and anyone interested in learning and growing. Don't miss this chance to expand your horizons, connect with peers, and fuel your success journey. RSVP today to secure your spot and mark your calendar! Let's come together, share our experiences, and inspire each other to reach new heights. Feel free to tag friends, colleagues, and anyone who might benefit from this event. Let's make it a vibrant and enriching gathering! See you there!
📣 On April 6th, Los Angeles becomes the epicenter of biotech brilliance at the #Biotech_Innovation_Funding_Networking event, proudly hosted by the joint forces of TiBIA (Taiwan Biomedical Innovation Association) and GeneOnline. Picture a gathering where the leaders of biotech, the architects of innovation, and the maestros of investment converge. It's your playground for discovering what's next in biotech and spotting the next unicorn in the making. Ready to let your achievements shine? Winners will be celebrated across GeneOnline and TiBIA's platforms, earning recognition and exclusive prizes that salute their groundbreaking contributions. 🏆 📅 April 6 2024 (Saturday) 🕘 1 - 5pm PDT ☀️ ScaleHealth 3415 S Sepulveda Blvd FL 10 Los Angeles, CA 90034 Join us! ➡️ https://lnkd.in/euDuGG4m TiBIA Website: https://lnkd.in/exUn5Eed
To view or add a comment, sign in
-
🚀 Big Fundraising News in Genomics! 🚀 Element Biosciences has just raised over $277 million in a Series D investment round to further its progress. This was led by Wellington Management and saw participation from major players including Samsung Electronics, Fidelity Investments and Foresite Capital. Element’s total fundraising now exceeds $680 million! Element’s install base of AVITI has skyrocketed from 40 to over 190 units in just a year! In a landscape long dominated by Illumina, Element Biosciences is bringing much-needed innovation and competition. Their focus on quality, cost-efficiency, and flexibility positions them as a disruptive force, particularly timely given the recent uncertainties surrounding Illumina (Grail). As a recruiter deeply invested in the life sciences sector, I’m incredibly excited about the potential of Element Biosciences to accelerate biological discovery and transform precision medicine. #LifeSciences #Genomics #PrecisionMedicine #Biotechnology #Innovation #ElementBiosciences #FundingNews #ScientificBreakthroughs #Illumina #Grail
To view or add a comment, sign in
-
BRAIN Biotech AG today informed during its #CapitalMarketsDay about its future corporate strategy. 🚀 The new segment #BRAINBiocatalysts will build the core of the corporate group´s future growth plans. By combining the two previous segments BioProducts and BioScience Zwingenberg, BRAIN Biotech is further sharpening its focus on the enzyme business and ensuring a more efficient integration of its research activities. Clear presentations and excellent talks by Aryan Moelker, Michael Schneiders, Alexander Pelzer, Andrew Ellis, Esther Gabor, and Daren Bryce Thank you to all the #investors and #analysts who joined us, whether in person or online! Read our press release: https://t1p.de/0pb47 #industrialenzymes #precisionfermentation #biosolutions #bioengineering #strategy #industrialbiotechnology #sustainability
To view or add a comment, sign in
-
Kind reminder for the coming webinar, presented by Dr. John Dulos, a renowned translational science expert and co-inventor of anti-PD1 pembrolizumab (Keytruda). Don't miss his talk 'Turning Setbacks into Success: Translational Science in Action'.
🚨 FREE Webinar - Sign Up Now! 🚨 Join our guest speaker John Dulos, a renowned translational science expert and co-inventor of anti-PD1 pembrolizumab (Keytruda), on his talk 'Turning Setbacks into Success: Translational Science in Action'. 📅 Date: Tuesday 1st October 2024 🕒 Time: 4-5pm Amsterdam time 👥 Hosted by: Venn Life Sciences - part of hVIVO plc Don’t miss this opportunity to turn setbacks into success! Register now: https://lnkd.in/ehvG66zT #Webinar #DrugDevelopment #TranslationalScience #Biomarkers
To view or add a comment, sign in
-
Frustrated by information silos hindering your early-stage drug discovery? Join us for this FREE one-day scientific conference on September 25th and unlock the potential of your research. Why Attend ChemTalks? ✔ Free access to cutting-edge knowledge: Gain valuable industry insights and learn the latest advancements in drug discovery. ✔ Bridge the gap, foster collaboration: Discover strategies to break down information barriers and work seamlessly with collaborators. ✔ Be the first to know: Stay ahead of the curve with exclusive access to Chemaxon's exciting new product roadmap. ✔ Expert advice: Get personalized guidance from renowned scientists and product managers. ✔ Actionable takeaways: Implement practical strategies to accelerate your research immediately. Don't miss this free opportunity! Register now and secure your spot: https://lnkd.in/gPPX5dYU #ChemTalks #DrugDiscovery #Breakthroughs #Collaboration #Innovation #Switzerland
To view or add a comment, sign in
-
🔬 With RNA constantly changing and innovating, we thought we should too! A new take on your traditional conference showcase 💰 If you're active in the RNA space (or a fan of shark tank 🦈), let's connect and have a chat #rna #biotech #investment #mrna #RNALeaders
📣Exciting news from RNA Leaders USA Congress 2024! We are proud to announce an incredible new addition to our event – the PolymeRAI$E. This exciting new feature gives early-stage innovators a unique platform to showcase their latest scientific advancements to RNA investors and potential partners and receive instant feedback. In a dynamic "shark tank" style format, each selected company will have the opportunity to pitch their innovations to our 2024 panel. Apply now and become an RNA Leader 🔗https://lnkd.in/eTc_eHYJ Panel Features: Eric Dai, Investor, Dimension Uli Stilz, Head of Bio Innovation Hub, Novo Nordisk Nick Mourlas, Head of J&J Innovation, Johnson & Johnson JLABS San Diego Geeta Vemuri, Founder & Managing Partner, Agent Capital Garrett Vygantas, M.D., Managing Partner, Riverine Ventures Kent Rogers, Venture Partner, ARCH Venture Partners Fay Xing, MD, Partner, Panacea Venture Leighanne Oh, M.S., VP, Ascenta Capital #RNALeaders #mRNA #rna #RNAinvestors #biotech #pharma
To view or add a comment, sign in
453 followers